Delivery Order SPE2DB24D2101-SPE2DB25FKNPJ
- Not listed
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $3,892.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,993.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $6,354.48 under a firm fixed-price contract. This non-set-aside delivery order, which is due for completion by July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $5,756.58 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract is a non-set-aside competitive award and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,051.05. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.39 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child delivery order under a larger contract vehicle, this award represents a specific pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,903.90 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens in 0.5 ml dosage units. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a non-competitive set-aside award and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNPJDelivery Order
The Defense Logistics Agency awarded a $3,003.00 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's prime indefinite delivery contract with the Defense Logistics Agency functions as a comprehensive global pharmaceutical support vehicle, enabling the supply of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support defense health operations worldwide. This specific delivery order for Trulicity, a diabetes management medication, exemplifies the company's role in providing essential brand-name pharmaceuticals through DLA's medical supply chain to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/18/25 |